Editorial on Upper Respiratory Tract Disorders

Lungs play a vital role in gas exchange by extracting oxygen for red blood cells and removing carbon dioxide. Their efficiency is notable and superior to industrial gas separation systems. In contrast to the natural gas exchange performed by the lungs, industrial gas exchange machines are used for production, separation, purification, and heat transfer. They move specific gases across membranes or barriers or enable controlled mixing to achieve desired compositions. Industrial gas exchange machines serve production, separation, purification, and heat transfer by controlling gas movement and composition through membranes and mixing. Key systems include Air Separation Units for cooling and separating gases by boiling point, Pressure Swing Adsorption Generators for selective adsorption under pressure, and Membrane Separation Systems for using semi-permeable membranes. Gas reclamation plants, heat exchangers, blowers, mixers, scrubbers, and analyzers each play targeted roles in gas management. Extracorporeal membrane oxygenation devices use similar concepts in health care. Understanding these industrial analogies can inspire and inform clinical approaches by highlighting the remarkable efficiency of natural lung function, which performs complex gas exchange seamlessly for decades without downtime or external maintenance. This could lead to innovations in respiratory therapy and support systems by replicating or optimizing these natural processes in medical devices. Comparing these machines to lungs highlights natural efficiency, offering inspiration for innovations in respiratory therapy and support systems. After considering the efficient function of lungs, it is important to understand the protective role of supporting anatomy. The only support for the lungs comes from the upper respiratory tract, which includes the nose, nasal cavity, sinuses, pharynx, and larynx. These parts warm, humidify, and filter incoming air as it moves toward the lungs. Hair and mucus in the nasal cavity trap dust and particles, whereas the sinuses connect to the nasal cavity. The pharynx serves as a passage for both air and food. The epiglottis, a flap of cartilage, prevents food from entering the airway during swallowing. The larynx sits below the pharynx and contains vocal cords, which vibrate to produce speech. Building on this, the upper respiratory tract is the first line of defense in gas exchange, protecting the lungs from environmental exposure. The upper respiratory tract encounters and neutralizes aerosols, allergens, pollens, chemicals, impurities, and carcinogens in various forms. Without this protection, lung function would decline much earlier. Infections, mainly viral and sometimes bacterial, are the most common upper respiratory illnesses. As per the NIH report last updated in 2025, up to 2021, the global burden of all-cause upper respiratory tract infections (URTIs) was 12.8 billion cases across all age groups, with an incidence rate of 162,484/100,000 people. Children under 2 had the highest rates; those between 5 and 9 had the most episodes. The mortality rate was 0.2/100,000, highest in newborns and the elderly. COVID-19 further increased this burden. Understanding the frequency of these infections further clarifies the clinical impact. Adults typically experience 2–5 colds per year. Children, who are the main reservoir for rhinovirus, have infection rates about four times higher, likely due to frequent contact in day care or school. Transmission occurs through aerosols, droplets, and contaminated surfaces, followed by self-inoculation. Psychosocial factors such as stress, depression, sleeplessness, smoking, and poor nutrition may increase susceptibility by impairing immune responses. Conventional care for upper respiratory infections (URIs) focuses on containing infection, limiting symptoms, and reducing distress but rarely eliminates the illness. As a result, years lived with disability remain high: 4.41 million in 2021, up from 3.34 million in 1990. In 2021, global disability-adjusted life years from URIs reached 5.68 million, up from 5.60 million in 1990, indicating significant morbidity and burden. This is per a 2025 study. Homoeopathy is also recognized for treating upper respiratory diseases, particularly infections of the nose, sinuses, ears, and larynx. While more than 130 homoeopathic remedies have been reported as effective, most of these claims are based on anecdotal evidence or individual reports rather than large-scale clinical trials. Consequently, the efficacy of these treatments remains under debate and requires further evidence-based validation. The exact number of research papers on homoeopathic treatment of URIs is difficult to determine because they are distributed across various publications. Systematic reviews indicate that more than dozens of studies exist. There are several review reports between 2010 and 2025 from several databases assessing the safety and efficacy of homoeopathy. A specific review published in 2019–2020 identified 21 randomized controlled trials and 19 comparative cohorts. These studies use different methods and report mixed results: some show benefits such as reduced symptoms, shorter illness duration, or reduced antibiotic use, whereas others find no effect compared to placebos or conventional care. Despite the variability in outcomes, clinicians may consider integrating homoeopathy as a complementary approach in conjunction with conventional treatments or homoeopathy as a standalone treatment, especially for patients seeking alternative therapies. It is important to assess each case individually, taking into account the patient’s condition, preferences, and response to treatments. To achieve optimal patient outcomes, managing URTIs requires an integrative approach among conventional physicians, homoeopaths, nurses, pharmacists, and other professionals. By combining expertise, these teams can prevent unnecessary prescriptions, reduce drug side effects, and improve patient-centered care. To facilitate this integration, teams could consider practical strategies such as joint case reviews to discuss complex cases and ensure comprehensive treatment plans. They might also establish shared protocols outlining each team member’s roles, ensuring consistent and coordinated care. Regular interprofessional meetings can foster communication and collaborative problem-solving, leading to a more effective and unified approach to patient management. Strong teamwork depends on effective professional communication that aligns the care team’s approach to URTI management. Shared decision-making and addressing patient expectations improve care coordination. For example, during team meetings, healthcare professionals could use phrases such as “Let’s review this patient’s case together to ensure we’re on the same page regarding treatment options” or “What are everyone’s thoughts on this treatment plan, and how might we present it to the patient?” In addition, role-playing scenarios in workshops, in which a pharmacist might express concerns about a prescription and a nurse discusses patient adherence strategies, can enhance team collaboration. Such practices ensure that all voices are heard and integrated into the patient care strategy. Teamwork and open communication help healthcare professionals improve patient adherence to evidence-based strategies, reduce antibiotic misuse, and optimize both team performance and outcomes in upper respiratory illnesses.